Surface Oncology, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$140.5M

234 transactions

Summary

Surface Oncology, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $42.5MSales: $96.9M46 insiders

Date	Insider	Type	Value
2023-08-01	ROSS ROBERT W.(Chief Executive Officer)	Sell	$16K
2023-08-01	FEES JESSICA(Chief Financial Officer)	Sell	$9K
2023-08-01	Adams Chandra(Deputy GC)	Sell	$4K
2023-09-08	ONEILL ALISON(Chief Medical Officer)	D	$0
2023-09-08	ONEILL ALISON(Chief Medical Officer)	D	—
2023-09-08	GRAYZEL DAVID S.	D	—
2023-09-08	ROSS ROBERT W.(Chief Executive Officer)	D	$0
2023-09-08	ROSS ROBERT W.(Chief Executive Officer)	D	—
2023-09-08	Goater Jeff	D	—
2023-09-08	RATH HENRY C.(Chief Business Officer)	D	$0
2023-09-08	RATH HENRY C.(Chief Business Officer)	D	—
2023-09-08	Adams Chandra(Deputy GC)	D	$0
2023-09-08	Adams Chandra(Deputy GC)	D	$0
2023-09-08	Adams Chandra(Deputy GC)	D	—
2023-09-08	Sigal Charles Elliott	D	$0
2023-09-08	Sigal Charles Elliott	D	—
2023-09-08	FEES JESSICA(Chief Financial Officer)	D	$0
2023-09-08	FEES JESSICA(Chief Financial Officer)	D	—
2023-09-08	Palombella Vito J.(Chief Scientific Officer)	D	$0
2023-09-08	Palombella Vito J.(Chief Scientific Officer)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Surface Oncology, Inc. — Contributions, Lobbying & Contracts | Poliscope